BRAF and central nervous system cancer: In certain studies, the KIAA1549:BRAF fusion gene was also found to function through MEK-dependent activation of both MAPK and mTOR pathways and the injection of neural stem cells containing the fusion were sufficient to induce glioma-like lesions in mice (29).